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Abstract 
Introduction. Dobutamine stress test (DST) is used as a method of  functional cardiac 
examination in human medicine due to dobutamine’s effect, which is similar to 
moderate physical exercise. The aim of  this study was to assess the feasibility and 
echocardiographic characteristics of  a conventional DST in dogs. 
Materials and Methods. Ten clinically healthy German Shepherd dogs were submitted 
to a conventional 3-minute stage DST protocol (the initial dose 7.5 µg/kg/min was 
increased at 3-minute intervals by 5 µg/kg/min until a maximum dosage of  42.5 µg/kg/
min; the maximum DST duration was 24 minutes), which is used in human medicine. 
Dobutamine action was monitored by noninvasive diagnostic methods (simultaneously 
lead II electrocardiography and transthoracic echocardiography). Left ventricular 
echocardiographic parameters were measured at baseline and at the peak of  DST. 
Results and Conclusions. The duration of  conventional DST in dogs was 19.4±4.06 
minutes. During the DST, sinus tachycardia was registered with no abnormalities of  
cardiac rhythm. The adverse effects registered in this study were excitement, panting 
and weakness. Interventricular septum thickness in systole (P=0.0093) and diastole 
(P=0.0080) increased significantly at the peak of  DST. The left ventricular end-
systolic dimension (P=0.0077) and the diastolic wall stress index (P=0.0125) decreased 
significantly at the peak of  DST. A 3-minute stage with increased doses of  dobutamine 
is a feasible method for the DST in dogs. The registered changes could be explained 
by the dobutamine effects through β1 adrenergic receptors. This pharmacological 
stress test induces significant changes in left ventricular echocardiographic parameters 
in healthy adult dogs. Dogs exhibit transient signs like sinus tachycardia, excitement, 
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panting and weakness during DST. Additional research on DST should evaluate the 
diagnostic value of  this protocol in dogs suffering from cardiac disease.
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INTRODUCTION
Dobutamine stress echocardiography (DSE) is accepted in human medicine as a 
noninvasive method for coronary artery disease diagnosis and risk stratification, 
detection of  myocardial ischemia and valvular dysfunction, evaluation of  cardiac versus 
noncardiac origin of  chest pain or dyspnea, as well as preoperative risk assessment. 
Contraindications for DSE in humans include conditions like acute myocardial 
infarction, acute pericarditis or myocarditis, symptomatic and severe aortic stenosis, 
stenotic valvular heart disease, main coronary artery stenosis, acute aortic dissection, 
uncontrolled and hemodynamically relevant arrhythmias, decompensated heart failure, 
pulmonary embolism, severe hypertension and severe electrolyte abnormalities. 
Conventional DSE protocols require graded infusions of  dobutamine using an 
escalating dose at 3-minute intervals, starting at a dose of  5 or 10 µg/kg/min and 
increasing by 10 µg/kg/min to a final dose of  40 µg/kg/min. However, no standardized 
dobutamine stress test (DST) exists in human medicine, and safety, feasibility and 
diagnostic accuracy of  different protocols were reported. These protocols vary from 
3-minute to 5-minute stage duration (Katritsis et al., 2005; Kamaran et al., 1995) and 
from a low dose (5 or 10 µg/kg/min) (Schinkel et al., 2004) to a high dose (20 and/or 
40 µg/kg/min) dobutamine infusion (San Roman et al., 2003; Lu et al., 2001). 
In canine cardiology, the pharmacological stress test is still in the investigational phase. 
Although DST has been already described in dogs by other authors (Suzuki et al., 
2014; Spasojevic Kosic et al., 2012; Sousa et al., 2005, 2004; McEntee et al., 2001, 2000, 
1998, 1996; Minors & O'Grady, 1998), the indications for DST in canine medicine are 
not well defined. Indications of  DSE in dogs could include an assessment of  cardiac 
functional capacity in patients where conventional and advanced echocardiographic 
analysis of  ventricular systolic function gave ambigous results. To date, reported  DST 
protocols in conscious dogs utilized low constant dose of  dobutamine infusion (5 
µg/kg/min) (Minors & O'Grady, 1998), as well as incremental dobutamine infusion 
(Spasojevic Kosic et al., 2012; Sousa et al., 2005, 2004; McEntee et al., 2001, 1998, 
1996). There is no data available on the subject of  comparing different DST protocols 
in conscious dogs, neither healthy dogs nor dogs with cardiac diseases.
In order to expand our knowledge of  DST in dogs, the conventional DST protocol 
used in human medicine was performed in this study. We wanted to explore whether 
or not this test is suitable for clinical examination and whether it had a similar 
echocardiographic profile as other reported DST protocols in dogs. Previous studies 
have investigated echocardiographic factors (Sousa et al., 2004; McEntee et al., 2001, 
1998; Minors & O'Grady, 1998) and hormonal response (Spasojevic Kosic et al., 
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2012; McEntee et al., 2000) associated with DST. In this paper, the effect of  the 
conventional DST on left ventricular echocardiographic parameters is presented as 
echocardiographic values obtained before and at the DST peak in order to compare its 
effects with the echocardiographic parameters values observed by other authors with 
different DST protocols. 
MATERIALS AND METHODS
Animals
Ten German Shepherd dogs owned by colleages (8 males and 2 females, 1 to 9 years 
old, body weight 26±4.57kg) were studied. The dogs were considered healthy based 
on the history, physical examination, complete blood count and serum chemistry, as 
well as conventional six-lead electrocardiography (ECG), and two-dimentional (2D) 
and M-mode echocardiography. All examinations were performed on conscious 
dogs using manual restraint. The experimental protocol was approved by the Ethical 
Committee of  the Faculty of  Veterinary Medicine, University of  Belgrade.
Dobutamine stress test
The DST was performed by administering dobutamine (Dobutamine, Panpharma 
S.A., Le Clairay, France) via the cephalic vein. The initial dose of  7.5 µg/kg/min was 
increased at 3-minute intervals, by 5 µg/kg/min, until a maximum dosage of  42.5 µg/
kg/min was achieved. The criterion of  maximum response to DST (DST peak) was 
fulfilled when the dog received the maximum dosage of  DST (42.5 µg/kg/min) or 
when one of  the following signs was detected: sinus tachycardia over 200/min, severe 
arrhythmia (paroxysmal ventricular tachycardia) or uncontrollable excitement of  the 
animal (McEntee et al., 1996). 
Echocardiographic examinations (300S Pandion Vet, Esaote Pie Medical, Maastricht, 
the Netherlands) were performed in 2D and M modes using a 5 MHz probe by 
an experienced veterinary internist with particular interest in cardiology. DSE was 
performed on the dogs in the standing position. Echocardiographic measurements 
were done from the right parasternal location by using two-dimensional guided 
M-mode echocardiograms. The M-mode cursor line was placed at the left ventricular 
chamber level, just below the tips of  the mitral valve in order to avoid papillary 
muscles within the left ventricle. Measurements were performed in accordance with 
the recommendations of  the American Society of  Echocardiography (Sahn et al., 
1978). The mean of  three cardiac cycles was taken as the result of  measurement. 
Echocardiographic values (interventricular septal thickness in diastole-IVSd, 
interventricular septal thickness in systole-IVSs, left ventricular end-diastolic 
dimension-LVEDD, left ventricular end-systolic dimension-LVESD, left ventricular 
free wall thickness in diastole-LVFWd, left ventricular free wall thickness in systole-
LVFWs) were measured before dobutamine administration and at the moment of  
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DST peak. During DST, the cardiac echocardiography (2D from right parasternal 
longitudinal axis) was monitored simultaneously in order to recognize maximum 
response to DST and to terminate dobutamine infusion. Continuous lead II ECG, 
which was integrated in the ultrasound machine, was monitored during DST in order 
to determine the heart rate (HR) and arrhythmia. 
The fractional shortening of  left ventricle (FS-LV), the left ventricular free wall percent 
thickening (LVW%T), the systolic wall stress index (WSIS) and the diastolic wall stress 
index (WSID) were calculated using the following formulas (Minors & O'Grady, 1998):
 
FS-LV (%) = LVEDD-LVESD/ LVEDD x 100 
LVW%T = 100 x (LVFWs-LVFWd) / LVFWd 
WSIS = LVESD / LVWs 
WSID = LVEDD / LVWd
Statistical analysis
Data analysis was performed using a commercial software package, Statistica 12. 
All quantitative variables are reported as the mean±standard deviation (SD). A 
nonparametric Wilcoxon matched pairs test was performed to compare the values of  
echocardiographic parameters from baseline to peak infusion. A probability value of  
P<0.05 was considered significant. Qualitative variables were expressed in percentages. 
RESULTS
All dogs tolerated the DST well. The average duration of  DST was 19.4±4.06 
minutes (13-24 minutes). The maximum level of  DST in the dogs was determined by 
monitoring HR, cardiac echo, ECG, and dogs’ behavior. In nine dogs, the end point of  
DST was reached at the HR>200/min. In one dog, there was no increase of  HR over 
200/min, despite the fact that this dog received the full dosage range of  dobutamine. 
Target HRs were observed at doses of  dobutamine ranging from 27.5-42.5 µg/
kg/min (mean peak dose 35.5±6.32). Only a sinus tachycardia (HR>200/min) was 
observed; no rhythm disturbances were observed during DST. After the termination 
of  dobutamine application, the HR decreased rapidly to a more physiological range of  
values (60-160/min). During DST, excitement, panting and weakness were observed 
in some dogs (Figure 1). None of  these side effects was judged to be severe enough to 
lead to interruption of  the experimental protocol. 
The dobutamine challenge resulted in IVSd and IVSs increases, a LVESD decrease, 
higher FS-LV and lower WSID (Table 1). The values of  IVSd (P=0.0080) and IVSs 
(P=0.0093) at the peak of  DST were significantly higher compared with baseline 
values. The LVESD at the peak of  DST was significantly different (P=0.0077) from 
the LVESD value before DST. The WSID was significantly lower at the peak of  DST 
compared with baseline values (P=0. 0125). 
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Figure 1. Percentages of  noncardiac adverse effects: (A) excitement, (B) panting, (C) weakness 
in dogs undergoing DST
Table 1. Echocardiographic parameters in dogs before dobutamine infusion and at the moment 
of  DST peak 
Parameters DST before DST peak p value
IVSd (cm) 0.72±0.08 0.84±0.09 0.0080
IVSs (cm) 0.92±0.11 1.07±0.08 0.0093
LVEDD (cm) 3.91±0.45 3.72±0.37 NS
LVESD (cm) 2.79±0.18 2.45±0.30 0.0077
LVFWd (cm) 0.79±0.15 0.86±0.10 NS
LVFWs (cm) 1.05±0.18 1.06±0.13 NS
FS–LV (%) 28.25±4.87 34.14±4.37 NS
LVW%T (%) 34.37±14.52 25.03±18.17 NS
WSIS 2.71±0.33 2.33±0.39 NS
WSID 5.05±0.56 4.41±0.83 0.0125
Data are presented as mean±SD. P < 0.05 = significant, NS = nonsignificant.
IVSd – interventricular septal thickness in diastole, IVSs – interventricular septal thickness in systole, 
LVEDD – left ventricular end – diastolic dimension, LVESD – left ventricular end – systolic dimension, 
LVFWd – left ventricular wall thickness in diastole, LVFWs – left ventricular wall thickness in systole, 
FS-LV – fractional shortening of  left ventricle, LVW%T – left ventricular free wall percent thickening, 
WSIS – systolic wall stress index, WSID – diastolic wall stress index.
DISCUSSION
Dobutamine is a potent β1 adrenergic agonist with minimal β2 and α adrenergic 
effects. The primary effect of  dobutamine infusion, as a diagnostic tool, constitutes 
an increase in HR and systolic blood pressure that results in an increase in myocardial 
oxygen demand, similar to that occurring during moderate physical exercise (Wackers, 
1993). DSE is accepted as a noninvasive method with defined indications and 
contraindications for evaluating the cardiovascular system in humans. In canine 
cardiology, DST has proved to be a sensitive, noninvasive diagnostic method for 
detecting early cardiac dysfunction in dogs with asymptomatic dilated cardiomyopathy 
(McEntee et al., 2001; Minors & O'Grady, 1998). The DST is especially effective 
in diagnosing systolic dysfunction provoked by doxorubicin (Sousa et al., 2004) or 
generated by mitral regurgitation (Suzuki et al., 2014). 
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High doses of  dobutamine in a DST induce myocardial ischemia both in humans 
(Coma-Canella, 1991) and dogs (Spasojevic Kosic et al., 2012), which supports the 
value of  the test. The ability of  the DST to detect myocardial ischemia in humans 
is dependent on an adequate increase in myocardial oxygen consumption, which is 
directly related to the HR achieved during stress (Tsutsui et al., 2005). The target 
HR of  stress echocardiography in human medicine is 85% of  the age and gender 
maximum predicted HR. Many patients in conventional DSE protocols do not reach 
the target HR and require atropine, which by removal of  parasympathetic tone, further 
augments the HR response (Mertes et al., 1993). In the studies of  McEntee et al. (1998, 
1996), target HRs were over 200/min or 240/min and maximum HRs were reached at 
a dosage ranging from 27.5- 42.5 µg/kg/min. HRs over 200/min were reached with 
the same doses in our study. Because the direct chronotropic effect of  dobutamine is 
neutralized by the reflex slowing of  HR due to baroreceptor reflex action (Liang et al., 
1981), after termination of  dobutamine application, we observed HR decreases.
Dobutamine pharmodynamics require approximately 10 minutes to reach a steady 
state. Despite this, standard DSE in humans typically uses 3-minute stages of  advancing 
dobutamine doses because of  safety concerns (Lu et al., 2001). In addition, DSE is 
considered time consuming and labor intensive, and it has been suggested that an 
accelerated protocol of  DST increases the feasibility and the cost effectivness of  stress 
echocardiography in human cardiology (SanRoman et al., 2003; Lu et al., 2001). This 
is even more important for veterinary medicine, because of  the uncooperativity of  the 
patients. In the studies of  McEntee et al. (McEntee et al., 2001, 1998, 1996), the dogs 
were trained to lie quietly on a table. The maximum time that dogs spent undergoing 
the procedure was 75 minutes. This duration of  test, under clinical circumstances, is 
too long for many dogs. In our study, the average duration of  DST was 19.4±4.06 
minutes, with the maximum DST duration being 24 minutes. Tolerance for this 
DST protocol was good. Occurrences of  adverse effects were lower than previously 
reported in healthy dogs evaluated with less aggressive DST protocols (Sousa et al., 
2005; McEntee et al., 1998, 1996). In many protocols, dobutamine is administered in 
higher doses than those for therapeutic purposes, potentially increasing the risk of  
adverse effects and complications. The most common cardiac adverse effects of  DST 
in humans are ischemia and benign arrhythmias (isolated premature atrial or ventricular 
complexes) (Mertes et al., 1993). In contrast, life-threatening arrhythmias, such as 
sustained ventricular tachycardia and ventricular fibrillation, are rare complications 
of  DSE (Lima et al., 2008; Katritsis et al., 2005; Mertes et al., 1993). Noncardiac 
adverse effects of  DST in humans are nausea, anxiety, headache, dizziness, tremor, 
dyspnea and urgency (SanRoman et al., 2003; Lu et al., 2001; Mertes et al., 1993). 
Adverse effects reported in dogs during dobutamine infusion were arrhythmias 
(ventricular premature complexes, paroxysmal ventricular tachycardia) (Sousa et al., 
2005; McEntee et al., 2000, 1998) panting, vomiting, congested mucous membranes 
and uncontrollable excitement (McEntee et al., 1998, 1996). In our study, the adverse 
effects of  dobutamine were mostly noncardiac (excitement and panting). 
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In humans, the DSE is coupled to an accurate analysis of  different segments of  the 
left ventricular walls to detect segmental changes of  myocardial function as a result of  
coronary artery disease. Such an echocardiographic approach has not been standardized 
in canine DST, and our echocardiographic analysis was limited to conventional 
M-mode analysis of  the global left ventricular function. It is expected that dobutamine 
has an influence on the left ventricular myocardium; however, LVFWd and LVFWs 
measurements did not show significant differences associated with DST. The lack 
of  statistical significance may reflect higher variability in the LVFW measurements 
compared to IVS measurements (Table 1). The results of  significantly increased 
IVSd (P=0.0080) and IVSs (P=0.0093) in our study suggest that dobutamine, at the 
used dosages, induces a more profound increase in septal myocardial contractility, 
as demonstrated in horses undergoing dobutamine or dobutamine/atropine stress 
echocardiography (Sandersen et al., 2006; Frye et al., 2003). A significant reduction 
of  LVESD (P=0.0077) after dobutamine infusion was observed, likely as result 
of  the positive inotropic action of  this drug. A similar mechanism could also 
explain the increased FS-LV (P=0.0593) observed during DST. Interstingly, similar 
echocardiographic changes have been previously reported by other authors in dogs 
undergoing DST (Sousa et al., 2004; McEntee et al., 2001; Minors & O'Grady, 1998). 
The diastolic wall stress index (WSID) is the echocardiographic parameter of  diastolic 
function. In healthy Dobermans subjected to low dobutamine infusion, the value of  
WSID decreased (5.2±0.18 vs. 5.1±0.12), while in Dobermans with occult dilated 
cardiomyopathy, the value of  this index increased (5.7±0.29 vs. 5.9±0.31), but the 
differences between the baseline and dobutamine examinations were not significant 
(Minors & O'Grady, 1998). In our study, with an aggressive DST protocol, the value 
of  WSID at the peak of  DST was significantly lower compared to the baseline value 
(5.05±0.56 vs. 4.41±0.83, P=0.0125). Since WSID represents a measure of  left 
ventricle preload (Aurigemma & Gaash, 2007), it could be presumed that preload is 
also reduced. Both the decrease in LVEDD and the increase in LVFWd, although 
nonsignificant, led to the diminishing of  WSID. Studies performed in dogs (McEntee 
et al., 1998), horses (Gehlen et al., 2006) and humans (Cnota et al., 2003) suggest the 
results of  a DST are related to decreased preload. In contrast to an exercise stress test, 
the muscular pump function that leads to increased venous return is missing during 
the DST (Cnota et al., 2003).
Certain limitations of  this study should also be addressed. Conventional DSE protocols 
in humans enable accurate analysis of  each myocardial segment. We based our study 
on the analysis of  left ventricular global function in order to compare fundamental 
echocardiographic parameters changes induced by the conventional DST with the ones 
previously reported in conscious dogs submitted to different DST protocols. Although 
our study was performed in dogs of  the same breed, we did not consider the influence 
of  body weight, age or gender on echocardiographic parameters. From the aspect of  
profound and detailed analysis of  ventricular function, the echocardiographic analysis 
of  conventional DST that we performed can be considered as a major limitation of  this 
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study. This is because advanced echocardiographic techniques such as tissue Doppler 
imaging and speckle-tracking echocardiography are superior (Suzuku et al., 2014; Hori 
et al., 2007). Potential exclusion criteria for DST in humans are certain arrhythmias 
and severe hypertension. In accordance with this, 24-hour Holter monitoring and 
oscillometric blood pressure measurement should have been incorporated into the 
study. The fact that DST was performed in a small number of  healthy animals requires 
additional studies of  conventional DST in dogs with known cardiovascular disease. 
Comparison of  different DST protocols in dogs has to be performed in order to 
provide standardization in cardiac functional assessment. 
CONCLUSION
The present study has provided a basis for conventional DST in dogs. The feasibility 
of  the conventional DST protocol used is acceptable primarily because it requires a 
shorter period of  time than some other protocols. In addition, the echocardiographic 
characteristics of  this conventional DST protocol were similar to those obtained in 
dogs with DST protocols of  longer duration. Lastly, the use of  3-minute stages in 
DST was safe and not associated with serious adverse effects in our population of  
healthy dogs. However, additional studies are needed in order to prove the safety and 
diagnostic accuracy of  this dynamic test in dogs with cardiac diseases. 
Acknowledgements
This study was performed at the Faculty of  Veterinary Medicine, University of  
Belgrade. The authors would like to thank Dr V. Magaš and Dr A. Spasović for their 
technical assistance.
Authors contributions
Lj. S. K. designed the study, performed all examinations, analyzed the results and wrote 
the manuscript. D. R. T. also designed the study, supervised the analysis of  the results, 
and contributed to the writing of  the manuscript.
Competing interests
The authors declare that they have no competing interests.
REFERENCES
Aurigemma, G.P., Gaasch, W.H. 2007. Quantitative evaluation of  left ventricular structure, wall 
stress and systolic function. In The practice of  clinical echocardiography. Ed. Otto, C.M. 
Saunders Philadelphia, pp. 187.
Cnota, J.F., Mays, W.A., Knecht, S.K., Kopser, S., Michelfelder, E.C., Knilans, T.K., Claytor, 
R.P., Kimball, T.R. 2003. Cardiovascular physiology during supine cycle ergometry and 
dobutamine stress. Medicine and Science in Sports and Exercise, 35:1503-1510. DOI: 
10.1249/01.MSS.0000084436.15808.52
Veterinarski Glasnik 2018, 72 (2), 90-100
98
Coma-Canella, I. 1991. Changes in plasma potassium during the dobutamine stress test. 
International Journal of  Cardiology, 33:55-59. DOI: https://doi.org/10.1016/0167-
5273(91)90152-F
Frye, M.A., Bright, J.M., Dargatz, D.A., Fettman, M.J., Frisbie, D.D., Baker, D.C., Traub-
Dargatz, J.L. 2003. A comparison of  dobutamine infusion to exercise as a cardiac stress 
test in healthy horses. Journal of  Veterinary Internal Medicine, 17:58-64. https://doi.
org/10.1111/j.1939-1676.2003.tb01324.x
Gehlen, H., Marnette, S., Rohn, K., Stadler, P. 2006. Stress echocardiography in wormblood horses: 
comparison of  dobutamine/atropine with treadmill exercise as cardiac stressors. Journal 
of  Veterinary Internal Medicine, 20:562-568. https://doi.org/10.1111/j.1939-1676.2006.
tb02897.x
Hori, Y., Sato, S., Hoshi, F., Huguchi, S. 2007. Assessment of  longitudinal tissue Doppler 
imaging of  the left ventricular septum and free wall as an indicator of  left ventricular 
systolic function in dogs. American Journal of  Veterinary Research, 68(10):1051-1057. 
https://doi.org/10.2460/ajvr.68.10.1051
Kamaran, M., Teague, S.M., Finkelhar, R.S., Dawson, N., Bahler, R.C. 1995. Prognostic 
value of  dobutamine stress echocardiography in patients referred because of  suspected 
coronary artery disease. American  Journal of   Cardiology, 76:887-891. DOI: https://doi.
org/10.1016/S0002-9149(99)80255-0
Katritsis, D.G., Karabinos, I., Papdopulos, A., Simeonidis, P., Korovesis, S., Giazityoglou, E., 
Karvouni, E., Voridis, E. 2005. Sustained ventricular tachycardia induced by dobutamine 
stress echocardiography: a prospective study. Europace, 7:433-439. https://doi.
org/10.1016/j.eupc.2005.05.009
Liang, C., Yi, J.M., Sherman, L.G., Black, J., Gavras, H., Hood, W.B. 1981. Dobutamine infusion 
in conscious dogs with and without acute myocardial infarction: Effects on systemic 
hemodynamics, myocardial blood flow, and infarct size. Circulation Research, 49:170-180.
Lima, R.deS.L., DeLorenzo, A., Issa, A. 2008. Reduced adverse effects with an accelerated 
dobutamine stress protcol compared wiith the conventional protocol: a prospective, 
randomiyed, myocardial perfusion scintigraphy study. International Journal of  
Cardiovascular Imaging, 24:55-59.
Lu, D., Greenberg, M., Little, R., Malik, Q., Fernicola, D.J., Weissman, N.J. 2001. Accelerated 
Dobutamine stress testing: safety and feasibility in patients with known or suspected 
coronary artery disease. Clinical Cardiology, 24:141-145. https://doi.org/10.1002/
clc.4960240208
McEntee, K., Amory, H., Pypendop, B., Balligand, M., Clercx, C., Michaux, C., Jacqmot, O., 
Robert, F., Gerard, P., Pochet, T., Henroteaux, M. 1998. Effects of  dobutamine on isovolumic 
and ejection phase indices of  cardiac contractility in conscious healthy dogs. Research in 
Veterinary Science, 64:45-50. https://doi.org/10.1016/S0034-5288(98)90114-X
McEntee, K., Clercx, C., Flandre, T., Jonvill, E., Pynnaert, C., van Benden, R., Ketelslegers, 
J.M., Michaux, C., Balligand, M., Miserque, N., Henroteaux, M. 2000. Hormonal response 
to dobutamine cardiac stress testing in a conscious canine model of  early left ventricular 
dysfunction induced by chronic rate overload. Journal of  Veterinary Cardiology, 2:7-14. 
https://doi.org/10.1016/S1760-2734(06)70006-6
McEntee, K., Clercx, C., Pypendop, B., Peeters, D., Balligand, M. 1996. Cardiac performance in 
conscious healty dogs during dobutamine infusion. Research in Veterinary Science, 61:234-
239. https://doi.org/10.1016/S0034-5288(96)90070-3
McEntee, K., Clercx, C., Soyeur, D., Amory, H., Michaux, C., Flandre, T., Jonville, E., 
Pynnaert, C., Miserque, N., Henroteaux, M. 2001. Usefulness of  dobutamine stress tests 
SPASOJEVIĆ KOSIĆ Ljubica, TRAILOVIĆ R. Dragiša: Convencional dobutamine stress test in dogs 
99
for detection of  cardiac abnormalities in dogs with experimentally induced early left 
ventricular dysfunction. American Journal of  Veterinary Research, 62:448-455. https://
doi.org/10.2460/ajvr.2001.62.448
Mertes, H., Sawada, S.G., Ryan, T., Segar, D.S., Kovacs, R., Folty, J., Feigenbaum, H. 1993. 
Symptoms, adverse effects and complications associated with dobutamine stress 
echocardiography. Experience in 1118 patients. Circulation, 88:15-19.
Minors, S.L., O’Grady, M.R. 1998. Resting and dobutamine stress echocardiography factors 
associated with the development of  occult dilated cardiomyopathy in healthy Doberman 
Pincher dogs. Journal of  Veterinary Internal Medicine, 12:369-380.
Sahn, D.J., DeMaria, A., Kisslo, J., Weyman, A. 1978. Recommendations regarding quantitation 
in M-mode echocardiography: results of  a survey of  echocardiographic measurements. 
Circulation, 58:1072-1083.
San Roman, J.A., Serrador, A., Ortega, J.R., Medina, A., Fernandez-Aviles, F. 2003. Diagnostic 
accuracy  of  a new shorter dobutamine infusion protocol in stress echocardiography. Heart, 
89:1089-1090. http://dx.doi.org/10.1136/heart.89.9.1089
Sandersen, C.F., Detilleux, J., deMoffarts, B., VanLoon, G., Amory, H. 2006. Effect of  atropine-
dobutamine stress test on left ventricular echocardiographic parameters in untrained 
warmblood horses. Journal of  Veterinary Internal Medicine, 20:575-580. https://doi.
org/10.1111/j.1939-1676.2006.tb02899.x
Schinkel, A.F.L., Vourvouri, E.C., Bax, J.J., Boomsma, F., Bountioukos, M., Rizzello, V., Biagini, 
E., Agricola, E., Elhendy, A., Roelandt, J.R.T.C., Poldermans, D. 2004. Relation between left 
ventricular contractile reserve during low dose dobutamine echocardiography and plasma 
concentrations of  natriuretic peptides. Heart, 90:293-296. http://dx.doi.org/10.1136/
hrt.2002.003822
Sousa, M.G., Carareto, R., Pereira-Neto, G.B., Gerardi, D.G., Camacho, A.A. 2004. Usefulness 
of  dobutamine stress test in the evaluation of  systolic function of  dogs with doxorubicin 
induced cardiomyopathy. Proceedings of  29th WSAVA, Free Communications, 
Rhodes, Greece, 6-8 October 2004, http://www.vin.com/proceedings/Proceedings.
plx?CID=WSAVA2004&0=Generic
Sousa, M.G., Pereira-Neto, G.B., Carareto, R., Gerardi, D.G., Camacho, A.A. 2005 Assessment 
of  eletrocardiographic parameters in healthy dogs undergoing dobutamine stress testing. 
Schweizer Archive Fur Tierheilkunde, 147:541-545. https://doi.org/10.1024/0036-
7281.147.12.541.
Spasojevic Kosic, Lj., Trailovic, D.R., Matunovic, R. 2012. Resting and dobutamine stress 
test induced serum concentration of  brain natriuretic peptide in German Shepherd dogs. 
Research in Veterinary Science, 93:1446-1453. https://doi.org/10.1016/j.rvsc.2012.04.002
Suzuki, R., Matsumoto, T., Teshima, T., Mochizuki, Y., Kozama, H. 2014. Dobutamine stress 
echocardiography for assessment of  systolic function in dogs with experimentally induced 
mitral regurgitation. Journal of  Veterinary Internal Medicine, 28:386-392.  https://doi.
org/10.1111/jvim.12293
Tsutsui, J.M., Lario, F.C., Fernandes, D.R., Kowatsch, I., Sbano, J.C., Franchini Ramires, J.A., 
Mathias, Jr.W. 2005. Safety and cardiac chronotropic responsivness to the early injection of  
atropine during dobutamine stress echocardiography in the elderly. Heart, 91:1563-1567. 
http://dx.doi.org/10.1136/hrt.2004.054445
Wackers, F.J.T. 1993. Which pharmacological stress is optimal, Editorial comment. Circulation, 
87:646-648.
Veterinarski Glasnik 2018, 72 (2), 90-100
100
IZVODLJIVOST I EHOKARDIOGRAFSKE KARAKTERISTIKE 
TROMINUTNOG DOBUTAMIN STRES TESTA KOD 
ZDRAVIH PASA
SPASOJEVIĆ KOSIĆ Ljubica, TRAILOVIĆ R. Dragiša
Kratak sadržaj
Uvod. Dobutamin stres test se koristi kao metod funkcionalnog ispitivanja srca u 
medicini zbog efekata dobutamina koji su slični onima koje izaziva umerena fizička 
aktivnost. Cilj ovog istraživanja je bio da proceni izvodljivost i ehokardiografske 
karakteristike konvencionalnog DST kod pasa. 
Materijal i metode. Deset klinički zdravih nemačkih ovčara je podvrgnuto konvencionalnom 
DST protokolu sa trominutnim intervalom aplikacije dobutamina (inicijalna doza od 
7.5 μg/kg/min je povećavana svaka 3 minuta za 5 μg/kg/min do maksimalne doze 
od 42.5 μg/kg/min; maksimalno trajanje DST je bilo 24 minuta), a koji se koristi u 
medicini. Delovanje dobutamina je praćeno neinvazivnim dijagnostičkim metodima 
(simultano elektrokardiografijom i ehokardiografijom). Ehokardiografski parametri 
leve komore su mereni pre i na vrhuncu DST.  
Rezultati i zaključak. Trajanje konvencionalnog DST kod pasa je bilo 19.4±4.06 minuta. 
Tokom DST registrovana je tahikardija bez poremećaja srčanog ritma. Neželjeni efekti 
DST u ovom ispitivanju su bili uzbuđenje, dahtanje i slabost. Debljina međukomornog 
septuma u sistoli (P=0.0093) i dijastoli (P=0.0080) se značajno povećala na vrhuncu 
DST. Dimenzija leve komore na kraju sistole (P=0.0077) i indeks dijastolnog stresa zida 
leve komore (P=0.0125) su se značajno smanjili na vrhuncu DST. Trominutni interval 
sa povećanjem doze dobutamina je izvodljiv DST protokol kod pasa. Registrovane 
promene mogu da se objasne delovanju dobutamina preko β1 adrenergičkih receptora. 
Ovaj farmakološki stres test izaziva značajne promene ehokardiografskih parametara 
leve komore kod odraslih zdravih pasa. Psi ispoljavaju prolazne znake sinusne 
tahikardije, uzbuđenja, dahtanja i slabosti tokom DST. Dodatna ispitivanja DST treba 
da procene dijagnostički značaj ovog protokola kod pasa koji pate od srčanih oboljenja. 
Ključne reči: dobutamin, ehokardiografija, farmakološki stres test, pas
